National Law Firm Baron and Budd Discusses Alleged Risk of Developing Type 2 Diabetes from Lipitor Use


The risk of developing Type 2 diabetes from Lipitor use appears greater in women

The national law firm of Baron and Budd is participating in outreach to help women taking statins understand the alleged dangers associated with medications such as Lipitor, a drug prescribed to lower cholesterol.

“This is a serious risk for women who take Lipitor,” said Russell Budd, president and managing shareholder of Baron and Budd. “Type 2 diabetes is a long-term and often dangerous condition that requires constant monitoring.”

The serious risks associated with type 2 diabetes include the increased likelihood for developing glaucoma and hypertension. In particular, hypertension is a significant danger as it can lead to an increased risk for strokes, heart attacks, and kidney disease. Patients who develop type 2 diabetes must also commit themselves to a routine of consistently monitoring blood sugar levels and watching diet and exercise, all disciplines that are significantly trying for many people. Unfortunately, type 2 diabetes is a long-term condition and there is no cure, so patients must watch their diets and monitor their blood sugar levels for the rest of their lives—even if the development of the disease came from the use of a statin drug such as Lipitor.

The Lipitor lawyers at Baron and Budd are now reviewing claims involving women who took Lipitor, had a body mass index (BMI) of 35 or under, and developed diabetes. You may be eligible to file a Lipitor lawsuit for no up-front cost. For a free and confidential evaluation of your potential case, please call us at 1.866.844.4556 or email us at Visit our website to learn more at:

Baron and Budd is recognized as one of the top plaintiffs’ law firms in the country and has successfully litigated many pharmaceutical cases. This year, Baron and Budd was picked as a finalist for the Public Justice 2013 Trial Lawyer of the Year Awards. Baron and Budd attorneys have been selected as finalists for the Trial Lawyer of the Year Award four times within the last six years.